Modifications

== Les publications dont Mme Savely est auteur ou co-auteur ==

== Les publications dont Mme Savely est auteur ou co-auteur ==

* <ref>https://www.ncbi.nlm.nih.gov/pubmed/16802385 Possible role of tick-borne infection in "cat-scratch disease": comment on the article by Giladi et al. Publié dans Arthritis Rheum en juillet 2006

* <ref>https://www.ncbi.nlm.nih.gov/pubmed/16802385 Possible role of tick-borne infection in "cat-scratch disease": comment on the article by Giladi et al. Publié dans Arthritis Rheum en juillet 2006</ref>

* <ref>https://journals.lww.com/journalofinfusionnursing/Abstract/2008/07000/Update_on_Lyme_Disease__The_Hidden_Epidemic.10.aspx Abstract: [[maladie de Lyme|Lyme disease]] is the most common vector-borne disease in the United States. Diagnosis is problematic for many reasons, including unsatisfactory laboratory tests and confusion about test interpretation. When [[maladie de Lyme|Lyme disease]] is diagnosed early, treatment is usually successful with oral antibiotics. Unfortunately, the diagnosis is often missed, allowing the infection to disseminate and affect every body system. When [[maladie de Lyme|Lyme disease]] affects the central nervous system, it is often treated with intravenous antibiotics in the home setting. Infusion nurses who are experienced with the myriad symptoms and treatment challenges of these complex patients will be a reassuring asset to patients and physicians alike.</ref>

* <ref>https://journals.lww.com/journalofinfusionnursing/Abstract/2008/07000/Update_on_Lyme_Disease__The_Hidden_Epidemic.10.aspx Abstract: [[maladie de Lyme|Lyme disease]] is the most common vector-borne disease in the United States. Diagnosis is problematic for many reasons, including unsatisfactory laboratory tests and confusion about test interpretation. When [[maladie de Lyme|Lyme disease]] is diagnosed early, treatment is usually successful with oral antibiotics. Unfortunately, the diagnosis is often missed, allowing the infection to disseminate and affect every body system. When [[maladie de Lyme|Lyme disease]] affects the central nervous system, it is often treated with intravenous antibiotics in the home setting. Infusion nurses who are experienced with the myriad symptoms and treatment challenges of these complex patients will be a reassuring asset to patients and physicians alike.</ref>

* <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177589/ Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Publié dans Int J Gen Med. en 2011</ref>

* <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177589/ Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Auteurs: Raphael B Stricker,1,3 Allison K DeLong,2 Christine L Green,1,3 Virginia R Savely,1,3 Stanley N Chamallas,1,4 and Lorraine Johnson1,3. Publié dans Int J Gen Med. en 2011. [...] En résumé, l'antibiothérapie intraveineuse prolongée est associée à une amélioration de la cognition, de la fatigue et des myalgies chez les patients référés pour un traitement de la maladie de Lyme neurologique. En revanche, l'amélioration des arthralgies n'a pas persisté après 1 à 4 semaines de traitement. Un traitement de 25 à 52 semaines peut être nécessaire pour obtenir une amélioration symptomatique significative chez les patients atteints de la maladie de Lyme neurologique.</ref>

== Liens externes ==

== Liens externes ==